Article Abstract
As palliative treatments for Alzheimer’s disease proliferate, the focus of therapeutics turns to drugs withthe potential to alter course. Evidence is reviewed, suggesting that there is biological plausibility to utilizinganti-inflammatory agents, antioxidants, free-radical scavengers, estrogen preparations, and perhaps cholinomimetics.This range of possibilities leads to an optimistic assessment of the likelihood for altering the courseor delaying the onset of Alzheimer’s disease.
From the Editors
Are you a healthcare provider?
Add your NPI to personalize your JCP experience.
Download Free PDF
This PDF is free for all visitors!
